Experimental periodontitis induced by Porphyromonas gingivalis does not alter the onset or severity of diabetes in mice

Journal of Periodontal Research

Volumn 48, Issue 5, 2013, Pages 582-590

  Li, H ^a   Yang, H ^a   Ding, Y ^a   Aprecio, R ^b   Zhang, W ^b   Wang, Q ^a,b   Li, Y ^b  

^a SICHUAN UNIVERSITY   (China)

^b LOMA LINDA UNIVERSITY   (United States)

Author keywords

Animal model; Diabetes; Periodontal disease; Porphyromonas gingivalis

Indexed keywords

STREPTOZOCIN; TUMOR NECROSIS FACTOR ALPHA;

ALVEOLAR BONE LOSS; ANIMAL; ANIMAL MODEL; ARTICLE; BACTEROIDACEAE INFECTION; BLOOD; BODY WEIGHT; C57BL MOUSE; COMPARATIVE STUDY; DIABETES MELLITUS; DIET RESTRICTION; DISEASE COURSE; DISEASE MODEL; EATING; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HYPERGLYCEMIA; INBRED MOUSE STRAIN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MICROBIOLOGY; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS; PATHOLOGY; PATHOPHYSIOLOGY; PERIODONTAL DISEASE; PERIODONTITIS; PHYSIOLOGY; PORPHYROMONAS GINGIVALIS; TRANSGENIC MOUSE;

ANIMAL MODEL; DIABETES; PERIODONTAL DISEASE; PORPHYROMONAS GINGIVALIS;

ALVEOLAR BONE LOSS; ANIMALS; BACTEROIDACEAE INFECTIONS; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; EATING; FASTING; HOMEOSTASIS; HYPERGLYCEMIA; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MICE, TRANSGENIC; PANCREAS; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; STREPTOZOCIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84883453256     PISSN: 00223484     EISSN: 16000765     Source Type: Journal    
DOI: 10.1111/jre.12041     Document Type: Article

References (48)

1. Brown LJ, Loe H. Prevalence, extent, severity and progression of periodontal disease. Periodontol 2000 1993;2:57-71.
2. Demmer RT, Jacobs DR Jr, Desvarieux M. Periodontal disease and incident type 2 diabetes. Diabetes Care 2008;31:1373-1379.
3. Khader YS, Dauod AS, El-Qaderi SS, Alkafajei A, Batayha WQ. Periodontal status of diabetics compared with nondiabetics: a meta-analysis. J Diabetes Complications 2006;20:59-68.
4. Salvi GE, Carollo-Bittel B, Lang NP. Effects of diabetes mellitus on periodontal and peri-implant conditions: update on associations and risks. J Clin Periodontol 2008;35:398-409.
5. Takeda M, Ojima M, Yoshioka H et al. Relationship of serum advanced glycation end products with deterioration of periodontitis in type 2 diabetes patients. J Periodontol 2006;77:15-20.
6. Sun WL, Chen LL, Zhang SZ, Ren YZ, Qin GM. Changes of adiponectin and inflammatory cytokines after periodontal intervention in type 2 diabetes patients with periodontitis. Arch Oral Biol 2010;55:970-974.
7. Preshaw P, Alba A, Herrera D et al. Periodontitis and diabetes: a two-way relationship. Diabtologia 2012;55:21-31.
8. Andersen CCP, Flyvbjerg A, Buschard K, Holmstrup P. Relationship between periodontitis and diabetes: lessons from rodent studies. J Periodontol 2007;78:1264-1275.
9. Genco CA, Van Dyke T, Amar S. Animal models for Porphyromonas gingivalis-mediated periodontal disease. Trends Microbiol 1998;6:444-449.
10. Lalla E, Lamster IB, Feit M et al. Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice. J Clin Invest 2000;105:1117-1124.
11. Kaplan JR, Wagner JD. Type 2 diabetes-an introduction to the development and use of animal models. ILAR J 2006;47:3.
12. Lalla E, Lamster IB, Feit M, Huang L, Schmidt AM. A murine model of accelerated periodontal disease in diabetes. J Periodontal Res 1998;33:387-399.
13. Baker PJ, Evans RT, Roopenian DC. Oral infection with Porphyromonas gingivalis and induced alveolar bone loss in immunocompetent and severe combined immunodeficient mice. Arch Oral Biol 1994;39:1035-1040.
14. Tatakis DN, Guglielmoni P. HLA-B27 transgenic rats are susceptible to accelerated alveolar bone loss. J Periodontol 2000;71:1395-1400.
15. Kuo LC, Polson AM, Kang T. Associations between periodontal diseases and systemic diseases: a review of the inter-relationships and interactions with diabetes, respiratory diseases, cardiovascular diseases and osteoporosis. Public Health 2008;122:417-433.
16. Löe H. Periodontal disease: the sixth complication of diabetes mellitus. Diabetes Care 1993;16:329-334.
17. Lalla E, Cheng B, Lal S et al. Periodontal changes in children and adolescents with diabetes. Diabetes Care 2006;29:295-299.
18. Javed F, Romanos GE. Impact of diabetes mellitus and glycemic control on the osseointegration of dental implants: a systematic literature review. J Periodontol 2009;80:1719-1730.
19. Tukey JW. Some thoughts on clinical trials, especially problems of multiplicity. Science 1977;198:679-684.
20. Kobayashi M, Kweon MN, Kuwata H et al. Toll-like receptor-dependent production of IL-12p40 causes chronic enterocolitis in myeloid cell-specific Stat3-deficient mice. J Clin Invest 2003;111:1297-1308.
21. Bolzán AD, Bianchi MS. Genotoxicity of streptozotocin. Mutat Res 2002;512:121-134.
22. Thomas JM, Contreras JL, Smyth CA et al. Successful reversal of streptozotocin-induced diabetes with stable allogeneic islet function in a preclinical model of type 1 diabetes. Diabetes 2001;50:1227-1236.
23. Kim JH, Stewart TP, Soltani-Bejnood M et al. Phenotypic characterization of polygenic type 2 diabetes in TALLYHO/JngJ mice. J Endocrinol 2006;191:437-446.
24. Kim JH, Sen S, Avery CS et al. Genetic analysis of a new mouse model for non-insulin-dependent diabetes. Genomics 2001;74:273-286.
25. Stewart TP, Kim HY, Saxton AM, Kim JH. Genetic and genomic analysisi of hyperlipidemia, obesity and diabetes using (C57BL/6J ×TALLYHO/JngJ) F2 mice. BMC Genomics 2010;11:713.
26. Cauchi S, Meyre D, Durand E et al. Post genome-wide association studies of novel genes associated with type 2 diabetes show gene-gene interaction and high predictive value. PLoS ONE 2008;3:e2031.
27. Didion SP, Lynch CM, Faraci FM. Cerebral vascular dysfunction in TallyHo mice: a new model of Type II diabetes. Am J Physiol Heart Circ Physiol 2007;292:H1579-H1583.
28. Won HY, Lee JA, Park ZS et al. Prominent bone loss mediated by RANKL and IL-17 produced by CD4 + T cells in TallyHo/JngJ mice. PLoS ONE 2011;6:e18168.
29. Chen H, Charlat O, Tartaglia LA et al. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 1996;84:491-495.
30. Weigle DS, Bukowski T, Foster D et al. Recombinant ob protein reduces feeding and body weight in the ob/ob mouse. J Clin Invest 1995;96:2065.
31. Baker P, Carter S, Dixon M, Evans R, Roopenian D. Serum antibody response to oral infection precedes but does not prevent Porphyromonas gingivalis-induced alveolar bone loss in mice. Oral Microbiol Immunol 1999;14:194-196.
32. Neiders M, Chen P, Suido H et al. Heterogeneity of virulence among strains of Bacteroides gingivalis. J Periodontal Res 1989;24:192-198.
33. Fletcher HM, Schenkein HA, Morgan RM, Bailey KA, Berry CR, Macrina FL. Virulence of a Porphyromonas gingivalis W83 mutant defective in the prtH gene. Infect Immun 1995;63:1521-1528.
34. Baker PJ, Dixon M, Evans RT, Roopenian DC. Heterogeneity of Porphyromonas gingivalis strains in the induction of alveolar bone loss in mice. Oral Microbiol Immunol 2000;15:27-32.
35. Andersen CCP, Flyvbjerg A, Buschard K, Holmstrup P. Periodontitis is associated with aggravation of prediabetes in Zucker fatty rats. J Periodontol 2007;78:559-565.
36. Nishikawa T, Naruse K, Kobayashi Y et al. Involvement of nitrosative stress in experimental periodontitis in diabetic rats. J Clin Periodontol 2012;39:342-349.
37. Mahamed DA, Marleau A, Alnaeeli M et al. G(-) anaerobes-reactive CD4 + T-cells trigger RANKL-mediated enhanced alveolar bone loss in diabetic NOD mice. Diabetes 2005;54:1477-1486.
38. Watanabe K, Petro BJ, Shlimon AE, Unterman TG. Effect of periodontitis on insulin resistance and the onset of type 2 diabetes mellitus in Zucker diabetic fatty rats. J Periodontol 2008;79:1208-1216.
39. Ide R, Hoshuyama T, Wilson D, Takahashi K, Higashi T. Periodontal disease and incident diabetes a seven-year study. J Dent Res 2011;90:41-46.
40. Li Q, Chalmers J, Czernichow S et al. Oral disease and subsequent cardiovascular disease in people with type 2 diabetes: a prospective cohort study based on the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation (ADVANCE) trial. Diabtologia 2010;53:2320-2327.
41. Sima C, Rhourida K, Van Dyke T, Gyurko R. Type 1 diabetes predisposes to enhanced gingival leukocyte margination and macromolecule extravasation in vivo. J Periodontal Res 2010;45:748-756.
42. Wetzler C, Kämpfer H, Stallmeyer B, Pfeilschifter J, Frank S. Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse: prolonged persistence of neutrophils and macrophages during the late phase of repair. J Invest Dermatol 2000;115:245-253.
43. Koulmanda M, Bhasin M, Awdeh Z et al. The role of TNF-a in mice with type 1- and 2- diabetes. PLoS ONE 2012;7:e33254.
44. Gurzov EN, Eizirik DL. Bcl-2 proteins in diabetes: mitochondrial pathways of β-cell death and dysfunction. Trends Cell Biol 2011;21:424-431.
45. Demmer RT, Squillaro A, Papapanou PN et al. Periodontal Infection, Systemic Inflammation, and Insulin Resistance Results from the Continuous National Health and Nutrition Examination Survey (NHANES) 1999-2004. Diabetes Care 2012;35:2235-2242.
46. Scheen AJ. From obesity to diabetes: why, when and who? Acta Clin Belg 2000;55:9-15.
47. Rhodes CJ. Type 2 diabetes-a matter of β-cell life and death? Sci STKE 2005;307:380.
48. Kahn S, Zraika S, Utzschneider K, Hull R. The beta cell lesion in type 2 diabetes: there has to be a primary functional abnormality. Diabtologia 2009;52:1003-1012.